Home > News > Eiffel to accelerate drug re-engineering efforts
June 3rd, 2004
Eiffel to accelerate drug re-engineering efforts
Eiffel said it plans to use its Supercritical Fluid (SCF) technology, designed to improve the efficacy of drugs and extend their patent life by reforming them into nano-sized particles that are easier for the body to absorb, in the area of asthma.
Arrowhead to Report Fiscal 2014 Third Quarter Financial Results- Conference Call Scheduled for Tuesday, August 12, 2014 - July 31st, 2014
New imaging agent provides better picture of the gut July 30th, 2014
Zenosense, Inc. July 29th, 2014
Optimum inertial design for self-propulsion: A new study investigates the effects of small but finite inertia on the propulsion of micro and nano-scale swimming machines July 29th, 2014